Retatrutide 20mg GLP3
- GLP-1 (Glucagon-like peptide 1)
- GIP (Glucose-dependent insulinotropic polypeptide)
- GCG (Glucagon)
Tirzepatide 30MG GLP2
- Better Blood Sugar Control: Over 90% of participants achieved their target HbA1c levels.
- Significant Weight Loss: Patients lost up to 20% of their body weight, often surpassing results from similar therapies.
- Cardiovascular Health: Studies suggest reduced cardiovascular risks, including improved cholesterol and blood pressure.
Tesamorelin 10mg (GHRH)
Benefits
- Muscle Growth: Tesamorelin peptide fosters muscle tissue growth and regeneration, rendering it a prized asset for athletes and fitness aficionados seeking performance augmentation.
- Fat Reduction: The tesamorelin peptide takes aim at diminishing obstinate adipose deposits, particularly in areas like the abdominal region, facilitating the realization of a more svelte physique.
- Enhanced Skin Health: Users have testified to improved skin texture and diminished wrinkles, positioning Tesamorelin 2mg as a potential anti-aging remedy.
- Elevated Energy Levels: A surge in vitality and overall energy often accompanies usage, contributing to a more dynamic and productive lifestyle.
Tesofensine, 0.25mg (50 tabs)
Active ingredient: Tesofensine Composition: Every tablet contains 250mcg of tesofensine Active life: 9 days Detection time: 2 weeks
Retatrutide 40mg GLP3
- GLP-1 (Glucagon-like peptide 1)
- GIP (Glucose-dependent insulinotropic polypeptide)
- GCG (Glucagon)
Beligas GLP3 Retatrutide 10mg
Retatrutide is developed for weight loss. In clinical trials, it has demonstrated the potential to help individuals lose over 20% of their body weight. This is a significant breakthrough, particularly for people who have not had success with traditional weight loss methods or other weight loss medications. By targeting multiple metabolic pathways, Retatrutide offers a more comprehensive solution to managing obesity. In addition to obesity, Retatrutide is being tested for its effectiveness in type 2 diabetes management. The drug helps regulate blood sugar levels while also promoting weight loss, which is crucial for people with type 2 diabetes. With better control over glucose and weight, patients may experience improved long-term outcomes and easier management of their diabetes. Another promising area of research for Retatrutide is its potential to treat fatty liver disease. Early studies indicate that the drug may help reduce liver fat in people with obesity, potentially preventing the progression of non-alcoholic fatty liver disease (NAFLD). This dual action on both weight and liver fat makes Retatrutide a unique treatment option for those at risk of liver complications.
Beligas GLP3 Retatrutide 5mg
- GLP-3 (Glucagon-like peptide 3)
- GIP (Glucose-dependent insulinotropic polypeptide)
- GCG (Glucagon)
